REFERENCES
- Van Gasse J T, Miller R F. Incidence of verruca plantaris (plantar warts) in a school population. Arch Pediatr 1958; 75: 279–84
- Rogozinski T T, Jablonska S, Jarzabek-Chorzelska M. Role of cell mediated immunity in spontaneous regression of plane warts. Int J Dermatol 1988; 27: 322–6
- Iwatsuki K, Tagami H, Takigawa M, et al. Plane warts under spontaneous resolution. Arch Dermatol 1986; 122: 655–9
- Thiele B, Mahrle G, Schuff-Warner P, et al. Verrucosis generalisata bei familiarem T-Helferzell-mangel; Behandlung mit interferon under tigason. Z Hautkr 1985; 60: 929–37
- Pueyo S, Criscuolo M, Davidovich C, et al. Treatment of recurrent common warts on low dose of intralesional natural human leukocyte interferon alpha. J Biol Regul Homeost Agents 1990; 4: 47–50
- Gibson J R, Harvey S G. Interferon in the treatment of persistent viral warts. Dermatologica 1984; 169: 47–8
- Gibson J R. Intralesional human lymphoblastoid interferon alpha for the treatment of cutaneous, nongenital viral warts. Arch Dermatol 1986; 122: 1098–9
- Pazin G J, Ho M, Haverkos H W, et al. Effects of interferon alpha on human warts. Interferon Res 1982; 2: 235–43
- Gibson J R, Harvey S G, Kemmett D. Treatment of common and plantar viral warts with human lymphoblastoid interferon alpha. Br J Dermatol 1986; 115(Suppl 31)76–9
- Vance J C, Bart B J, Hansen R C, et al. Intralesional recombinant alpha-2 interfron for the treatment of patients with condyloma accuminatum or verruca plantaris. Arch Dermatol 1986; 122: 272–7
- Weck P K, Buddin D A, Wisnant J K. Interferons in the treatment of genital human papillomavirus infections. Am J Med 1988; 85: 159–64
- Douglas J M, Eron L J, Judson F N, et al. A randomised trial of combination therapy with intralesional interferon alpha (2b) and podophyllin versus podophyllin alone for the therapy of anogenital warts. J Infect Dis 1990; 162: 52–9
- Vance J C, Davis D. Interferon alpha-2b injections used as an adjuvant therapy for carbon dioxide laser vaporisation of recalcitrant ano-genital condylomata acuminata. J Invest Dermatol 1990; 95(Suppl)146–8
- Hohenleutner U, Landthaler M, Braun-Falco O. Postoperative adjuvant therapy with interferon alpha-2b following laser surgery for condylomata accuminata. Hautarzt 1990; 41: 545–8
- Sand Peterson C, Bjerring P, Larsen J, et al. Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple resistant genital warts: a placebo controlled study. Genitourin Med 1991; 67: 99–102
- Tiedmann K H, Ernst Th M. Combination therapy of recurrent condylomata accuminata with electrocautery and alpha-2-interferon. Aktuelle Dermatol 1988; 14: 200–4
- Burman B, Davis-Reed L, Silverstein L, et al. Treatment of verruca vulgaris with alpha2 interferon. J Infect Dis 1986; 154: 328–30
- Gross G, Ikenberg H, Roussaki A, et al. Systemic treatment of condylomata acuminata with recombinant intereferon-alpha-2a: low dose superior to high dose regime. Chemotherapy 1986; 32: 537–41
- Nimura M. Application of β-interferon in virus-induced papillomas. J Invest Dermatol 1990; 95: 149–51